Skip to content

ML Pharma

Active Private limited companyfounded 2023active for 3 yearsHouba de Strooperlaan 773, 1020 BrusselsKBO/BCE: BE 0795.627.454
ML Pharma
Follow ReportCompare

Board

1 director, since incorporation
IGASS Amale
Director (not named in the articles)
since 02-01-2023 term without a fixed end
listed in the 2025 annual accounts, filed on 03-07-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
IGASS Amale
Director (not named in the articles)
Board
Mandates as a list
  • IGASS Amale
    • Director (not named in the articles), from 02-01-2023 to date

Control

Founder
IGASS Amale
This company
ML Pharma
Equity €122,318
Profit €13,891 in 2025

Capital

Contribution
€10,000
Shares
100
Contribution per share
€100
Equity per share
€1,223 in 2025
Source
deed of 04-01-2023

Articles of association

deed of 04-01-2023 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of June at 19:00
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
No statutory auditor

Founder

At incorporation deed of 04-01-2023 ↗

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure